AB0404 Ultrasonographic Evaluation of Iguratimod Therapy in Patients with Japanese Rheumatoid Arthri...
AB0404 Ultrasonographic Evaluation of Iguratimod Therapy in Patients with Japanese Rheumatoid Arthritis
About this item
Full title
Author / Creator
Kanayama, Y. , Nagasaka, H. , Shimotake, M. , Miyachi, F. , Fujita, K. , Ishii, Y. and Nagata, A.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
More information
Scope and Contents
Contents
BackgroundIguratimod (IGU) is a small-molecule antirheumatic drug that was approved in Japan in September 2012. IGU suppressed tumor necrosis factor-alpha-induced production of interleukin (IL)-6, IL-8, and monocyte chemoattractant protein 1 via inhibition of nuclear factor kappa B activation in cultured human synovial cells and human acute monocyt...
Alternative Titles
Full title
AB0404 Ultrasonographic Evaluation of Iguratimod Therapy in Patients with Japanese Rheumatoid Arthritis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1901841313
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1901841313
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2016-eular.6076
